Clinical Trials Logo

Nemaline Myopathy clinical trials

View clinical trials related to Nemaline Myopathy.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT00272883 Recruiting - Clinical trials for Centronuclear Myopathy

Molecular and Genetic Studies of Congenital Myopathies

Start date: August 2003
Phase:
Study type: Observational

In the Congenital Myopathy Research Program at Boston Children's Hospital and Harvard Medical School, the researchers are studying the congenital myopathies (neuromuscular diseases present from birth), including central core disease, centronuclear/myotubular myopathy, congenital fiber type disproportion, multiminicore disease, nemaline myopathy, rigid spine muscular dystrophy, SELENON (SEPN1), RYR1 myopathy, ADSS1 (ADSSL) Myopathy and undefined congenital myopathies. The primary goal of the research is to better understand the genes and proteins (gene products) involved in muscle functioning and disease. The researchers hope that our studies will allow for improved diagnosis and treatment of individuals with congenital myopathies in the future. For more information, visit the Laboratory Website at www.childrenshospital.org/research/beggs